Lactate/Albumin Ratio as a Prognostic Factor for Short-time Mortality in Critically Ill Patients with Coronavirus Disease-2019

Abstract

Objective:The prognostic role of the initial lactate/albumin ratio (LAR) in critically ill patients with coronavirus disease-2019 (COVID-19) remains unknown. This study aimed to evaluate the prognostic value of the initial LAR in predicting 30-day mortality in critically ill patients with COVID-19 and compare the initial level of serum lactate and albumin for mortality prediction.Materials and Methods:A single-center and observational clinical study between April 2020 and December 2020 were retrospectively performed. Clinical and laboratory variables of patients evaluated in this study were collected within the first 24 hours following the intensive care unit (ICU) admission.Results:A total of 282 critically ill patients with COVID-19 were included in the study. The mean age of the patients was 66.34±12.08 years, wherein 179 (63.5%) were male. Patients who died within 30 days had higher lactate (p0.60.Conclusion:LAR is a useful prognostic factor for risk stratification of critically ill patients with COVID-19.

Keywords

• covid-19
• lactate/albumin ratio
• lactate
• albumin
• mortality
• predictor